SCORE performance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
064947/Z/01/Z
Wellcome Trust - United Kingdom
081081/Z/06/Z
Wellcome Trust - United Kingdom
1R01 AG23522
NIA NIH HHS - United States
PubMed
23786858
PubMed Central
PMC3938861
DOI
10.1093/eurheartj/eht189
PII: eht189
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiovascular mortality, Cardiovascular risk factors, Central and Eastern Europe, Former Soviet Union, Risk prediction, SCORE risk function,
- MeSH
- ateroskleróza mortalita MeSH
- dospělí MeSH
- hodnocení rizik MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mortalita trendy MeSH
- prognóza MeSH
- rozložení podle pohlaví MeSH
- senioři MeSH
- věkové rozložení MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
- Litva epidemiologie MeSH
- Polsko epidemiologie MeSH
- Rusko epidemiologie MeSH
AIMS: The Systematic COronary Risk Evaluation (SCORE) scale assesses 10 year risk of fatal atherosclerotic cardiovascular disease (CVD), based on conventional risk factors. The high-risk SCORE version is recommended for Central and Eastern Europe and former Soviet Union (CEE/FSU), but its performance has never been systematically assessed in the region. We evaluated SCORE performance in two sets of population-based CEE/FSU cohorts. METHODS AND RESULTS: The cohorts based on the World Health Organization MONitoring of trends and determinants in CArdiovascular disease (MONICA) surveys in the Czech Republic, Poland (Warsaw and Tarnobrzeg), Lithuania (Kaunas), and Russia (Novosibirsk) were followed from the mid-1980s. The Health, Alcohol, and Psychosocial factors in Eastern Europe (HAPIEE) study follows Czech, Polish (Krakow), and Russian (Novosibirsk) cohorts from 2002-05. In Cox regression analyses, the high-risk SCORE ≥5% at baseline significantly predicted CVD mortality in both MONICA [n = 15 027; hazard ratios (HR), 1.7-6.3] and HAPIEE (n = 20 517; HR, 2.6-10.5) samples. While SCORE calibration was good in most MONICA samples (predicted and observed mortality were close), the risk was underestimated in Russia. In HAPIEE, the high-risk SCORE overpredicted the estimated 10 year mortality for Czech and Polish samples and adequately predicted it for Russia. SCORE discrimination was satisfactory in both MONICA and HAPIEE. CONCLUSION: The high-risk SCORE underestimated the fatal CVD risk in Russian MONICA but performed well in most MONICA samples and Russian HAPIEE. This SCORE version might overestimate the risk in contemporary Czech and Polish populations.
Zobrazit více v PubMed
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757. PubMed
World Health Organisation. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO; 2007.
Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001;30:427–432. PubMed
Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart. 2006;92:1752–1759. PubMed PMC
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J. 2012;33:1635–1701. PubMed
Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356–362. PubMed
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003. PubMed
World Health Organisation. Health for All database http://data.euro.who.int/hfamdb (30 November 2012)
Tunstall-Pedoe Hugh, editor. World Health Organisation MONICA Project. MONICA Monograph and Multimedia Sourcebook: World's Largest Study of Heart Disease, Stroke, Risk Factors and Population Trends 1979–2002. Geneva: 2003. WHO MONICA Project.
Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355:675–687. PubMed
Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, Pikhart H, Nicholson A, Marmot M. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006;6:255. PubMed PMC
Cifkova R, Byma S, Ceska R, Horky K, Karen I, Kunesova M, Kralikov E, Rosolova H, Roztocil K, Soska V, Skhra J. Prevence kardiovaskularnich onemocneni v dospelem veku. Spolecne doporuceni ceskych odbornych spolecnosti. Supplementum Cor Vasa. 2005;47:3–14.
Podolec P, Kopec G, Pajak A, Undas A, Kozek E, Tykarski A, Naruszewicz M, Stanczyk J, Opala G, Godycki-Cwirko M, Rynkiewicz A, Torbicki A, Musial J. Polish forum for prevention guidelines on cardiovascular risk assessment. Kardiol Pol. 2007;65:100–104. PubMed
Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC, Jr, Wilson PW. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–2416. PubMed PMC
Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604. PubMed
Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387. PubMed
Lee ET, Go OT. Survival analysis in public health research. Annu Rev Public Health. 1997;18:105–134. PubMed
Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087–1091. PubMed
Rubin DB. Multiple imputation after 18+ Years. J Am Stat Assoc. 1996;91:473–489.
World Health Organisation. Global InfoBase https://apps.who.int/infobase/Index.aspx (30 November 2012)
Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet. 2011;377:578–586. PubMed
Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet. 2011;377:568–577. PubMed
Ulmer H, Kollerits B, Kelleher C, Diem G, Concin H. Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women. Eur J Cardiovasc Prev Rehabil. 2005;12:433–441. PubMed
Vlismas K, Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas Y, Stavrinos V, Stefanadis C. The role of dietary and socioeconomic status assessment on the predictive ability of the HellenicSCORE. Hellenic J Cardiol. 2011;52:391–398. PubMed
Aspelund T, Thorgeirsson G, Sigurdsson G, Gudnason V. Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project. Eur J Cardiovasc Prev Rehabil. 2007;14:761–768. PubMed
Lindman AS, Veierod MB, Pedersen JI, Tverdal A, Njolstad I, Selmer R. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway. Eur J Cardiovasc Prev Rehabil. 2007;14:501–507. PubMed
van Dis I, Kromhout D, Geleijnse JM, Boer JM, Verschuren WM. Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example. Eur J Cardiovasc Prev Rehabil. 2010;17:244–249. PubMed
De Bacquer D, De Backer G. Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. Int J Cardiol. 2010;143:385–390. PubMed
Ketola E, Laatikainen T, Vartiainen E. Evaluating risk for cardiovascular diseases—vain or value? How do different cardiovascular risk scores act in real life. Eur J Public Health. 2009;20:107–112. PubMed
Comin E, Solanas P, Cabezas C, Subirana I, Ramos R, Gene-Badia J, Cordon F, Grau M, Cabre-Vila JJ, Marrugat J. Estimating cardiovascular risk in Spain using different algorithms. Rev Esp Cardiol. 2007;60:693–702. PubMed
Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, Conroy R, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham I. How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil. 2009;16:304–314. PubMed
Cooney MT, Vartiainen E, Laatikainen T, Joulevi A, Dudina A, Graham I. Simplifying cardiovascular risk estimation using resting heart rate. Eur Heart J. 2010;31:2141–2147. PubMed
Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt P, Olsen MH. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31:883–891. PubMed
Mendis S, Lindholm LH, Anderson SG, Alwan A, Koju R, Onwubere BJ, Kayani AM, Abeysinghe N, Duneas A, Tabagari S, Fan W, Sarraf-Zadegan N, Nordet P, Whitworth J, Heagerty A. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings. J Clin Epidemiol. 2011;64:1451–1462. PubMed